Stereotaxis Profit Margin

The latest profit margin for STXS is -74.24% as of June 2026. That compares with -77.51% in the prior-year period — up 4.2% year over year. That is below the Healthcare sector average of 14.41%. Investors often review this figure alongside Stereotaxis's historical trend and sector peers before judging valuation or financial health.

Over the past year, STXS's profit margin moved from -77.51% to -74.24% — a 4.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Stereotaxis's valuation or profitability profile.

Against Healthcare companies, STXS currently prints -74.24% for profit margin, while the sector average sits near 14.41%. That is roughly 615.1% below the sector mean. Large gaps often invite a closer look at Stereotaxis's growth, margins, and balance sheet.

Profit Margin shows how effectively Stereotaxis converts resources into returns. At -74.24%, STXS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -77.51% in the prior-year period — up 4.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting STXS's profit margin (-74.24%), review year-over-year change from -77.51%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.